Valeriano, Jeric A.
HRN: 20-74-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/11/2023
06/18/2023
PO
5ml
TID
Laryngopharyngeal Reflux Disease With GERD Cannot Totally Rule Out Esophageal Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes